Access Resources
1826 - 1850 of 7616 Results
Title
Year
-
RESTRICTEDTitle: Automated Video Monitoring of Unmarked and Marked Honey Bees at the Hive EntranceJournal Name: Frontiers in Computer SciencePublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fcomp.2021.769338Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcomp.2021.769338/pdfCitation Count: 3
-
RESTRICTEDTitle: Blood GFAP as an emerging biomarker in brain and spinal cord disordersJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 158End Page: 172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-021-00616-3Best OA location URL: https://www.nature.com/articles/s41582-021-00616-3.pdfCitation Count: 207
- Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy2022RESTRICTEDTitle: Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2113489119Best OA location URL: https://doi.org/10.1073/pnas.2113489119Citation Count: 40
- Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies2022RESTRICTEDTitle: Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding RibosomopathiesJournal Name: Frontiers in Molecular BiosciencesPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmolb.2022.805541Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmolb.2022.805541/pdfCitation Count: 2
-
RESTRICTEDTitle: Mapping dopaminergic projections in the human brain with resting-state fMRIJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.71846Best OA location URL: https://doi.org/10.7554/elife.71846Citation Count: 10
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 297End Page: 310Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13412Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13412Citation Count: 2
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 311End Page: 325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13415Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13415Citation Count: 2
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022RESTRICTEDTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 5
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022RESTRICTEDTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 4
-
RESTRICTEDTitle: GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1016End Page: 1027Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28932Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28932Citation Count: 46
- Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic2022RESTRICTEDTitle: Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 PandemicJournal Name: Frontiers in Public HealthPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpubh.2021.772805Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpubh.2021.772805/pdfCitation Count: 4
- 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activation2022RESTRICTEDTitle: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 179Issue #:Start Page: 74End Page: 82Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849140Citation Count: 6
- A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration2022RESTRICTEDTitle: A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105612End Page: 105612Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105612Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105612Citation Count: 1
-
RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 1
-
RESTRICTEDTitle: Association of Essential Tremor With Novel Risk LociJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 185End Page: 185Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4781Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2787239/jamaneurology_liao_2022_oi_210083_1644604359.06757.pdfCitation Count: 18
-
RESTRICTEDTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 1
- Competitive Displacement of De Novo Designed HeteroDimers Can Reversibly Control Protein–Protein Interactions and Implement Feedback in Synthetic Circuits2022RESTRICTEDTitle: Competitive Displacement of De Novo Designed HeteroDimers Can Reversibly Control Protein–Protein Interactions and Implement Feedback in Synthetic CircuitsJournal Name: GEN BiotechnologyPublisher: Mary Ann Liebert IncVol: 1Issue #: 1Start Page: 91End Page: 100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/genbio.2021.0011Citation Count: 4
-
RESTRICTEDTitle: Deep Learning‐Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1064End Page: 1069Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28933Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28933Citation Count: 14
- Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease Impulsivity2022RESTRICTEDTitle: Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease ImpulsivityJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 91Issue #: 4Start Page: 370End Page: 379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.03.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419208Citation Count: 3
-
RESTRICTEDTitle: Editorial introductionsJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 35Issue #: 1Start Page: viiEnd Page: ixPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000001027Best OA location URL: https://journals.lww.com/co-neurology/Fulltext/2022/02000/Editorial_introductions.1.aspxCitation Count: 0
-
RESTRICTEDTitle: Functional neurological disorder and somatic symptom disorder in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120017End Page: 120017Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120017Citation Count: 12
-
RESTRICTEDTitle: GBA mutations, glucosylceramide and Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 72Issue #:Start Page: 148End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.conb.2021.11.004Citation Count: 23
- Genetic variants in progranulin upstream open reading frames increase downstream protein expression2022RESTRICTEDTitle: Genetic variants in progranulin upstream open reading frames increase downstream protein expressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 110Issue #:Start Page: 113End Page: 121Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.09.007Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.09.007Citation Count: 1
- Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging2022RESTRICTEDTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804990Citation Count: 5
- Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level2022RESTRICTEDTitle: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 213End Page: 225Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-021-00999-yBest OA location URL: https://www.nature.com/articles/s41593-021-00999-y.pdfCitation Count: 214